Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

23 Inhibitors Reports

Global Interleukin Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: AbbVie, Inc, Johnson and Johnson, Novartis AG, Eli Lilly and Company, GlaxoSmithKline Plc

Enzyme Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: Abbott Laboratories, AstraZeneca PLC, Bayer Ag, Boehringer Ingelheim International GmbH, Amgen Inc.

Tyrosine Kinase Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Boehringer Ingelheim International, F. Hoffmann-La Roche, AstraZeneca plc, Novartis AG, Bayer AG

Proton Pump Inhibitors Industry

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Bayer AG, Pfizer Inc., Takeda Pharmaceuticals, Cadila Pharmaceuticals, AstraZeneca

Asia Pacific DPP Drugs Market

Study Period: 2018 - 2029

Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Europe Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Latin America Alpha-Glucosidase Inhibitors Industry

Study Period: 2019 - 2029

Countries Covered: Brazil, Mexico

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Middle East And Africa Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Takeda, Pfizer, Bayer, SunPharma, Glenmark

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Alpha Glucosidase Inhibitor Drugs Market

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

PD1 and PDL1 Inhibitors Industry

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche AG, Pfizer Inc., GSK plc

Immune Checkpoint Inhibitor Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Bristol Myers Squibb Company, Regeneron Pharmaceuticals Inc, AstraZeneca plc, F. Hoffmann-La Roche AG, Merck & Co Inc

Plasma Protease C1-inhibitor Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: CSL Behring LLC, Takeda Pharmaceutical Company Limited (Shire Pharmaceutical Holdings), Pharming Technologies B.V., KalVista Pharmaceuticals, Inc., BioCryst Pharmaceuticals

Esomeprazole Market

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Viatris Inc., DAIICHI SANKYO COMPANY, LIMITED, Sun Pharmaceutical Industries Ltd.

MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market

Study Period: 2019 - 2029

Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Astrazeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Astellas

Latin America Sodium-Glucose Cotransport-2 Inhibitor Industry

Study Period: 2019 - 2029

Countries Covered: Brazil, Mexico

Major Players: Astrazeneca, Eli Lilly, Astellas, Bristol Myers Squibb, Janssen

DPP4 Drugs Industry

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Study Period: 2021- 2029

Countries Covered: United States, Canada

Major Players: Merck, AstraZeneca, Eli lilly, Boehringer Ingelheim Pharmaceuticals Inc., Novartis

Latin America DPP-4 Inhibitors Industry

Study Period: 2019 - 2029

Countries Covered: Mexico, Brazil

Major Players: AstraZeneca, Novartis, Boehringer Ingelheim, Merck and Co., Eli Lilly and Company

DDP4 Inhibitors Industry in Europe

Study Period: 2018 - 2029

Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia

Major Players: AstraZeneca, Takeda, Novartis, Merck & Co., Inc., Eli Lilly and Company

North America Alpha-Glucosidase Inhibitors Industry

Study Period: 2019- 2029

Major Players: Takeda, Pfizer, Bayer, Sunpharma, Glenmark

Imatinib Drug Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Sun Pharmaceutical Industries Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan N.V, Dr. Reddy's Laboratories

Tumor Necrosis Factor Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Asia Pacific, Middle East and Africa, South America

Major Players: UCB Inc, Pfizer Inc, Johnson & Johnson, Amgen Inc., Abbvie

Filter Reports

By Region

By Countries